AstraZeneca | AZN - Bénéfice Avant Impôts

Prix De L'Action
13,562.00
Variation Quotidienne
232.00 1.74%
Mensuellement
-9.33%
Annuel
29.11%
Q2 Prévisions
13,283.65




Bénéfice Avant Impôts Changement Date
AbbVie USD 5.57B 2.9B 2026-03
Alcon AG USD 264M 19M 2025-12
Almirall EUR 30.32M 22M 2025-12
Amgen USD 1.51B 2.41B 2025-12
argenx SE USD 386.05M 99.15M 2025-09
AstraZeneca USD 3.91B 1.28B 2026-03
Autolus Therapeutics Ltd USD -91.52M 12.93M 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 377.7M 433.7M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 340M 168.46M 2026-03
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Haleon GBP 537.5M 249.5M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Merck USD 3.42B 3.32B 2025-12
Novartis USD 3.84B 802M 2026-03
Orion EUR 113.4M 213.6M 2026-03
Pfizer USD -1.64B 4.98B 2025-12
Philips EUR 275M 62M 2025-09
Recordati EUR 144.95M 25.46M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06